Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1979 1
1980 6
1981 4
1982 10
1983 18
1984 14
1985 31
1986 17
1987 33
1988 35
1989 29
1990 41
1991 33
1992 35
1993 27
1994 29
1995 35
1996 36
1997 35
1998 52
1999 63
2000 48
2001 55
2002 63
2003 72
2004 100
2005 97
2006 89
2007 98
2008 101
2009 134
2010 166
2011 206
2012 223
2013 207
2014 243
2015 251
2016 282
2017 331
2018 338
2019 332
2020 55
Text availability
Article attribute
Article type
Publication date

Search Results

3,711 results
Results by year
Filters applied: . Clear all
Page 1
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease.
Kam TI, Mao X, Park H, Chou SC, Karuppagounder SS, Umanah GE, Yun SP, Brahmachari S, Panicker N, Chen R, Andrabi SA, Qi C, Poirier GG, Pletnikova O, Troncoso JC, Bekris LM, Leverenz JB, Pantelyat A, Ko HS, Rosenthal LS, Dawson TM, Dawson VL. Kam TI, et al. Science. 2018 Nov 2;362(6414):eaat8407. doi: 10.1126/science.aat8407. Science. 2018. PMID: 30385548 Free PMC article.
DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors.
Pillay N, Tighe A, Nelson L, Littler S, Coulson-Gilmer C, Bah N, Golder A, Bakker B, Spierings DCJ, James DI, Smith KM, Jordan AM, Morgan RD, Ogilvie DJ, Foijer F, Jackson DA, Taylor SS. Pillay N, et al. Cancer Cell. 2019 Mar 18;35(3):519-533.e8. doi: 10.1016/j.ccell.2019.02.004. Cancer Cell. 2019. PMID: 30889383 Free PMC article.
Mechanisms of PARP inhibitor sensitivity and resistance.
D'Andrea AD. D'Andrea AD. DNA Repair (Amst). 2018 Nov;71:172-176. doi: 10.1016/j.dnarep.2018.08.021. Epub 2018 Aug 23. DNA Repair (Amst). 2018. PMID: 30177437 Review.
Biomarkers for Homologous Recombination Deficiency in Cancer.
Hoppe MM, Sundar R, Tan DSP, Jeyasekharan AD. Hoppe MM, et al. J Natl Cancer Inst. 2018 Jul 1;110(7):704-713. doi: 10.1093/jnci/djy085. J Natl Cancer Inst. 2018. PMID: 29788099 Review.
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells.
Noordermeer SM, van Attikum H. Noordermeer SM, et al. Trends Cell Biol. 2019 Oct;29(10):820-834. doi: 10.1016/j.tcb.2019.07.008. Epub 2019 Aug 14. Trends Cell Biol. 2019. PMID: 31421928 Free article. Review.
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions.
Zimmermann M, Murina O, Reijns MAM, Agathanggelou A, Challis R, Tarnauskaitė Ž, Muir M, Fluteau A, Aregger M, McEwan A, Yuan W, Clarke M, Lambros MB, Paneesha S, Moss P, Chandrashekhar M, Angers S, Moffat J, Brunton VG, Hart T, de Bono J, Stankovic T, Jackson AP, Durocher D. Zimmermann M, et al. Nature. 2018 Jul;559(7713):285-289. doi: 10.1038/s41586-018-0291-z. Epub 2018 Jul 4. Nature. 2018. PMID: 29973717 Free PMC article.
3,711 results
Jump to page
Feedback